KYLE LIBAN: Open Payments
NPI 1912301466 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 13 payments from 7 companies in 2025. Trend: 2023 $924 · 2024 $562 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 4 | $233 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $90 |
| Kestra Medical Technology Services, Inc. | 1 | $49 |
| ABIOMED | 1 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: Attruby, LifeVest, Assure WCD, JARDIANCE, REPATHA, Kerendia.
Industry payments across NY — which companies pay providers there.
